{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T09:15:22Z","timestamp":1759482922130},"reference-count":5,"publisher":"Japanese Society of Internal Medicine","issue":"15","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2021,8,1]]},"DOI":"10.2169\/internalmedicine.6807-20","type":"journal-article","created":{"date-parts":[[2021,2,14]],"date-time":"2021-02-14T22:13:54Z","timestamp":1613340834000},"page":"2519-2519","source":"Crossref","is-referenced-by-count":3,"title":["Benralizumab as a First-line Treatment for ABPA: Is It Really Indicated?"],"prefix":"10.2169","volume":"60","author":[{"given":"Ritesh","family":"Agarwal","sequence":"first","affiliation":[{"name":"Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research (PGIMER), India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valliappan","family":"Muthu","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research (PGIMER), India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Matsuura H, Fujiwara K, Omori H, et al. Successful treatment with benralizumab for allergic bronchopulmonary aspergillosis that developed after disastrous heavy rainfall in Western Japan. Intern Med 60: 1443-1450, 2021.","DOI":"10.2169\/internalmedicine.6217-20"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Denning DW, Park S, Lass-Florl C, et al. High-frequency triazole resistance found in nonculturable <i>Aspergillus<\/i> fumigatus from lungs of patients with chronic fungal disease. Clin Infect Dis 52: 1123-1129, 2011.","DOI":"10.1093\/cid\/cir179"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Dhooria S, Sehgal IS, Muthu V, Agarwal R. Treatment of allergic bronchopulmonary aspergillosis: from evidence to practice. Future Microbiol 15: 365-376, 2020.","DOI":"10.2217\/fmb-2019-0276"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Agarwal R, Dhooria S, Sehgal IS, et al. A randomised trial of voriconazole and prednisolone monotherapy in acute-stage allergic bronchopulmonary aspergillosis complicating asthma. Eur Respir J 52: 1801159, 2018.","DOI":"10.1183\/13993003.01159-2018"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Eraso IC, Sangiovanni S, Morales EI, Fern\u00e1ndez-Trujillo L. Use of monoclonal antibodies for allergic bronchopulmonary aspergillosis in patients with asthma and cystic fibrosis: literature review. Ther Adv Respir Dis 14: 1753466620961648, 2020.","DOI":"10.1177\/1753466620961648"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/15\/60_6807-20\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,7]],"date-time":"2021-08-07T03:54:19Z","timestamp":1628308459000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/15\/60_6807-20\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,1]]},"references-count":5,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.6807-20","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,1]]},"article-number":"6807-20"}}